Printer Friendly Version
Emily Savas concentrates on complex pharmaceutical patent litigations. She regularly represents generic drug manufacturers in all aspects of federal intellectual property litigation, including pre-litigation regulatory activities, Paragraph IV Certifications and notice letters, invalidity and non-infringement contentions, review and production of electronically stored information, written discovery, fact witness depositions, claim construction proceedings, expert discovery, motion practice, as well as pretrial preparations.
Emily has additional experience practicing before the United States Patent and Trademark Office. She has extensive experience in trademark prosecution and litigation. She has represented business owners in disputes regarding trademark ownership and infringement, including summary judgment proceedings and expert discovery. Emily has prosecuted trademarks for a variety of business types, as well as a non-profit student organization promoting access to essential medicines. Additionally, she is a registered patent agent with an advanced degree in molecular biology.
Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.